Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants
Funds an addition to an existing NIH grant, to take a cancer biomarker assay from working in the lab to working in the clinic.
The National Cancer Institute funds a great many assays that never leave the laboratory that built them. This route pays to close that gap — but only for people who already hold the grant that produced the assay.
What it funds is adapting and clinically validating molecular, cellular and imaging markers for cancer detection, diagnosis, prognosis, monitoring and predicting response to treatment, p…
Adapting and clinically validating molecular, cellular and imaging biomarkers for cancer detection, diagnosis, prognosis, monitoring and prediction of treatment response, and for cancer control and prevention — including acquiring annotated specimens where validation requires them. Early-stage technology development and running clinical trials are both out of scope.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up